Previous Close | 0.2200 |
Open | 0.2000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.2000 - 0.2000 |
52 Week Range | 0.1100 - 0.5400 |
Volume | |
Avg. Volume | 4,178 |
Market Cap | 1.601M |
Beta (5Y Monthly) | 0.58 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0390 |
Earnings Date | Nov 14, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for ISCO
SAN DIEGO, CA / ACCESSWIRE / May 17, 2022 / International Stem Cell Corporation (OTC PINK:ISCO) (www.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and financial results for the three months ended March 31, 2022.
SAN DIEGO, CA / ACCESSWIRE / March 30, 2022 / International Stem Cell Corporation (OTCQX:ISCO) (www.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced fourth quarter and year-end financial results for the period ending on December 31, 2021.